Bad-Drug Ads or Killer Ads: The Effects of Drug Injury Advertising on Public Health

References

• Agha L, Zeltzer D (2022) Drug diffusion through peer networks: The influence of industry payments. Amer. Econom. J. Econom. Policy 14(2):1–33.Crossref, Google Scholar
• Anderson SP, Ciliberto F, Liaukonyte J, Renault R (2016) Push-me pull-you: Comparative advertising in the OTC analgesics industry. RAND J. Econom. 47(4):1029–1056.Crossref, Google Scholar
• Avery R, Kenkel D, Lillard DR, Mathios A (2007) Private profits and public health: Does advertising of smoking cessation products encourage smokers to quit? J. Political Econom. 115(3):447–481.Crossref, Google Scholar
• Behrens MA (2019) United States: Deceptive plaintiff lawyer advertising is harmful to public health…and states are taking action. Accessed August 11, 2023, https://www.tortreform.com/news/united-states-deceptive-plaintiff-lawyer-advertising-is-harmful-to-public-healthand-states-are-taking-action/.Google Scholar
• Chiou L, Tucker CE (2022) How do restrictions on advertising affect consumer search? Management Sci. 68(2):866–882.Link, Google Scholar
• CMS (2018) Medicare Part D Prescriber Public Use Files (Centers for Medicare and Medicaid Services, Washington, DC).Google Scholar
• Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, et al. (2009) Dabigatran versus warfarin in patients with atrial fibrillation. New England J. Medicine 361(12):1139–1151.Crossref, Google Scholar
• Federal Trade Commission (2019) FTC flags potentially unlawful TV ads for prescription drug lawsuits. Accessed April 18, 2023, https://www.ftc.gov/news-events/news/press-releases/2019/09/ftc-flags-potentially-unlawful-tv-ads-prescription-drug-lawsuits.Google Scholar
• Fong J, Guo T, Rao A (2023) Debunking misinformation about consumer products: Effects on beliefs and purchase behavior. J. Marketing Res. 61(4):659–681.Google Scholar
• Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, et al. (2011) Apixaban versus warfarin in patients with atrial fibrillation. New England J. Medicine 365(11):981–992.Crossref, Google Scholar
• Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann. Internal Medicine 146(12):857–867.Crossref, Google Scholar
• Hristakeva S, Mortimer JH (2023) Price dispersion and legacy discounts in the national television advertising market. Marketing Sci. 42(6):1162–1183.Link, Google Scholar
• Institute for Legal Reform (2017) Bad for your health: Lawsuit advertising implications and solutions. Technical report, U.S. Chamber Institute for Legal Reform, Washington, DC.Google Scholar
• Karmasek J (2016) AMA: Lawyer ads are alarming prescription drug users, jeopardizing health care. Forbes (July 21), https://www.forbes.com/sites/legalnewsline/2016/07/21/ama-lawyer-ads-are-alarming-prescription-drug-users-jeopardizing-health-care/.Google Scholar
• Kim T, KC D (2020) Can Viagra advertising make more babies? Direct-to-consumer advertising on public health outcomes. J. Marketing Res. 57(4):599–616.Crossref, Google Scholar
• King J, Tippett E (2020) Drug injury advertising. Yale J. Health Policy Law Ethics 18(2):3.Google Scholar
• Lewis RA, Rao JM (2015) The unfavorable economics of measuring the returns to advertising. Quart. J. Econom. 130(4):1941–1973.Crossref, Google Scholar
• Liaukonyte J, Teixeira T, Wilbur KC (2015) Television advertising and online shopping. Marketing Sci. 34(3):311–330.Link, Google Scholar
• Mohamoud M, Patanavanich S, Crew P, McCulley L, Munoz M, Kortepeter C, Jones SC, et al. (2019) Discontinuation of direct oral anticoagulants in response to attorney advertisements: Data from the FDA adverse event reporting system. Ann. Pharmacotherapy 53(9):962–963.Crossref, Google Scholar
• Morozov I, Tuchman A (2024) Where does advertising content lead you? We created a bookstore to find out. Marketing Sci. 43(5):986–1001.Link, Google Scholar
• Niederdeppe J, Avery RJ, Kellogg MD, Mathios A (2017) Mixed messages, mixed outcomes: Exposure to direct-to-consumer advertising for statin drugs is associated with more frequent visits to fast food restaurants and exercise. Health Comm. 32(7):845–856.Crossref, Google Scholar
• Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, et al. (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England J. Medicine 365(10):883–891.Crossref, Google Scholar
• Rao A (2022) Deceptive claims using fake news advertising: The impact on consumers. J. Marketing Res. 59(3):534–554.Crossref, Google Scholar
• Rao A, Wang E (2017) Demand for “healthy” products: False claims and FTC regulation. J. Marketing Res. 54(6):968–989.Crossref, Google Scholar
• Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, et al. (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. Lancet 383(9921):955–962.Crossref, Google Scholar
• Shapiro BT (2018a) Informational shocks, off-label prescribing, and the effects of physician detailing. Management Sci. 64(12):5925–5945.Link, Google Scholar
• Shapiro BT (2018b) Positive spillovers and free riding in advertising of prescription pharmaceuticals: The case of antidepressants. J. Political Econom. 126(1):381–437.Crossref, Google Scholar
• Shapiro BT (2022) Promoting wellness or waste? Evidence from antidepressant advertising. Amer. Econom. J. Microeconom. 14(2):439–477.Crossref, Google Scholar
• Sinkinson M, Starc A (2018) Ask your doctor? Direct-to-consumer advertising of pharmaceuticals. Rev. Econom. Stud. 86(2):836–881.Crossref, Google Scholar
• Tippett E (2015) Medical advice from lawyers: A content analysis of advertising for drug injury lawsuits. Amer. J. Law Medicine 41(1):7–48.Crossref, Google Scholar
• Tippett E, King J, Lucent V, Ephraim S, Murphy M, Taff E (2018) Does attorney advertising influence patient perceptions of pelvic mesh? Urology 111:65–71.Crossref, Google Scholar
• Troy A, Anderson TS (2021) National trends in use of and spending on oral anticoagulants among US Medicare beneficiaries from 2011 to 2019. JAMA Health Forum 2(7):e211693.Crossref, Google Scholar
• Tsai Y-L, Honka E (2021) Informational and noninformational advertising content. Marketing Sci. 40(6):1030–1058.Abstract, Google Scholar
• Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, et al. (2022) Heart disease and stroke statistics—2022 update: A report from the American Heart Association. Circulation 145(8):e153–e639.Crossref, Google Scholar
• Tuchman AE (2019) Advertising and demand for addictive goods: The effects of e-cigarette advertising. Marketing Sci. 38(6):994–1022.Abstract, Google Scholar
• Unger EF (2015) Atrial fibrillation and new oral anticoagulant drugs. Accessed April 18, 2023, https://www.fda.gov/drugs/news-events-human-drugs/atrial-fibrillation-and-new-oral-anticoagulant-drugs.Google Scholar
• Wang G, Zhang Z, Ayala C, Dunet DO, Fang J, George MG (2014) Costs of hospitalization for stroke patients aged 18–64 years in the United States. J. Stroke Cerebrovascular Diseases 23(5):861–868.Crossref, Google Scholar
• Yoon TJ, Kim TIT (2023) The role of advertising in high-tech medical procedures: Evidence from robotic surgeries. J. Marketing 88(1):97–115.Google Scholar
• Yousufuddin M, Young N (2019) Aging and ischemic stroke. Aging (Albany NY) 11(9):2542–2544.Crossref, Google Scholar